Periodontal disease and atherosclerotic cardiovascular disease: Confounding effects or epiphenomenon?

Pharmacotherapy

Volumn 20, Issue 7 I, 2000, Pages 805-818

  Chong, Pang H ^a   Kezele, Bob ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE;

BACTERIUM CULTURE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; HUMAN; PATHOGENESIS; PERIODONTAL DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0033922478     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.9.805.35189     Document Type: Review

References (72)

1. World Health Organization. The world health report 1995; bridging the gaps. Geneva: World Health Organization, 1995:1.
2. Coles KA, Plant AJ, Riley TA, Smith DA. Cardiovascular disease: an infectious aetiology? Rev Med Microbiol 1998;9:17-27.
3. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. Periodontitis: a risk factor for coronary heart disease? Ann Periodontol 1998;3:127-41.
4. Brown LJ, Loe H. Prevalence, extent, severity and progression of periodontal disease. Periodontol 2000 1993;2:57-71.
5. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
6. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am Heart J 1999;138(suppl pt 2):434S-7.
7. Glauser MP. The inflammatory cytokines: new developments in the pathophysiology and treatment of septic shock. Drugs 1996;52(suppl 2):9-17.
8. Anonymous. Periodontal disease as a risk factor for systemic diseases. J Periodontol 1998;69:841-50.
9. Kinane DF. Periodontal diseases' contribution to cardiovascular disease: an overview of potential mechanisms. Ann Periodontol 1998;3:142-50.
10. Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
11. Carlquist JF. Endotoxin: another phantom menace? [editorial]. J Am Coll Cardiol 1999;34:1982-4.
12. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
13. Gurfinkel EP, Bozovich G, Livellara G, et al. Antibiotics for the treatment of non Q wave coronary syndromes: the final report of the ROXIS trial. Eur Heart J 1999;20:121-7.
14. Saikku P, Lainonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary artery disease and acute myocardial infarction. Lancet 1988;2:983-6.
15. Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol 1998;32(suppl 3):62S-6.
16. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodontol 1998;3:108-20.
17. Listgarten MA. The role of dental plaque in gingivitis and periodontitis. J Clin Periodontol 1988;15:485-7.
18. Silver JG, Martin AW, McBride BC. Experimental transient bacteremias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol 1980;4:92-9.
19. Carroll GC, Sebor RJ. Flossing and its relationship to transient bacteremia. J Periodontol 1980;51:691-2.
20. Sconyers JR, Crawford JJ, Moriarty JD. Relationship of bacteremia to toothbrushing in patients with periodontitis. J Am Dent Assoc 1973;87:616-22.
21. Korman KS. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 1999;28:520-6.
22. Schett G, Metzler B, Kleindienst R, et al. Salivary anti-hsp65 antibodies as a diagnostic marker for gingivitis and a possible link to atherosclerosis. Int Arch Allergy Immunol 1997;114:246-50.
23. Ebersole J, Machen R, Steifen M, Willmann D. Systemic acute-phase reactants, C-reactive protein and haptoglobin in adult periodontitis. Clin Exp Immunol 1997;107:347-52.
24. Loos B, Hutter J, Varoufaki H, et al. Levels of C-reactive protein in periodontitis patients and healthy controls [abstr]. J Dent Res 1998;77:666.
25. Sammalkorpi K, Valtonen V, Kerttula Y, et al. Changes in serum lipoprotein pattern induced by acute infection. Metabolism 1988;37:859-65.
26. Kweider M, Lowe GDO, Murray GD, Kinane D, McGown D. Dental disease, fibrinogen and white cell count: links with myocardial infarction? Scot Med J 1993;38:73-4.
27. Lowe GDO. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine. Ann Periodontol 1998;3:121-6.
28. Herzberg MC, Meyer MW. Dental plaque, platelets, and cardiovascular diseases. Ann Periodontol 1998;3:151-60.
29. Tobias PS, Gegner J, Tapping R, Gegner JA. Lipopolysaccharide-dependent cellular activation. J Periodont Res 1997;32:99-103.
30. Gonzalez-Amaro R, Diaz-Gonzales F, Sanchez-Madrid F. Adhesion molecules in inflammatory disease. Drugs 1998;56:977-88.
31. Mitchinson MJ. Macrophages and atherogenesis. Lancet 1987;2:521-32.
32. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. In vivo protection against endotoxin by plasma high density lipoprotem. Proc Natl Acad Sci USA 1993;90:1240-4.
33. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
34. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontol 1991;26:230-42.
35. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999;96:272-7.
36. Herzberg MC, MacFarlane GD, Gong K. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infect Immunol 1992;60:4809-18.
37. Hertzberg M, MacFarlane G, Liu P, et al. The platelet as an inflammatory cell in periodontal diseases: interactions with Porphyromonas gingivalis. In: Genco R, Hamada S, Lehner T, McGhee J, Mergenhagen S, eds. Molecular pathogenesis of periodontal disease. Washington, DC: American Society of Microbiology Press, 1994:247-55.
38. Haraszthy VI, Zambon JJ, Trevisan M, Shah R, Zeid M, Genco RJ. Identification of pathogens in atheromatous plaques [abstr]. J Dent Res 1998;77:666.
39. Dorn BR, Dunn WA, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immunol 1999;67:5792-8.
40. Beck J, Garcia R, Heiss G, Vokonase P, Offenbacher S. Periodontal disease and cardivascular disease. J Periodontol 1996;67:1123-37.
41. Beck JD, Offenbacher S. Oral health and systemic disease: periodontitis and cardiovascular disease. J Dent Educ 1998;62:859-70.
42. Offenbacher S, Collins JG, Yalta B, et al. Role of prostaglandins in high risk periodontitis patients. In: Genco R, Hamada S, Lehner T, McGhee J, Mergenhagen S, eds. Molecular pathogenesis of periodontal disease. Washington, DC: American Society of Microbiology Press, 1994:203-14.
43. Hernichel-Gorbach E, Kornman KS, Holt SC. Host responses in patients with generalized refractory periodontitis. J Periodontol 1994;65:8-16.
44. 2, IL-1β, IL-6 and TNF-α by monocytes from early-onset periodontitis patients. J Periodontol 1994;65:139-46.
45. Salvi GE, Brown CE, Fujihashi K, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontol Res 1998;4:212-25.
46. Kornman KS, Crane A, Wang H-Y, et al. The interleukin-1 genotype as a severity factors in adult periodontal disease. J Clin Periodontol 1997;24:72-7.
47. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ 1993;306:688-91.
48. Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK. Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995;20:588-92.
49. Joshipura KJ, Rimm EB, Douglass CW, Trichopulos D, Ascherio A, Willett WC. Poor oral health and coronary heart disease. J Dent Res 1996;75:1631-6.
50. Morrison HJ, Ellison LF, Taylor GW. Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 1999;6:7-11.
51. Beck JD, Pankow J, Tyroler HA, Offenbacher S. Dental infections and atherosclerosis. Am Heart J 1999;138(suppl pt 2):528S-33.
52. Christen WG, Hennekens CH, Ajani A, et al. Periodontal disease and risks of cardiovascular disease [abstr]. Circulation 1997;97:821.
53. Genco R, Chadda S, Grossi S, et al. Periodontal disease is a predictor of cardiovascular disease in a Native American population [abstr]. J Dent Res 1997;76:408.
54. Mattila K, Nieminen M, Valtonen V, et al. Association between dental health and acute myocardial infarction. Br Med J 1989;298:779-82.
55. Mattila K, Valle MS, Nieminen MS, et al. Dental infections and coronary atherosclerosis. Atherosclerosis 1993;103:205-11.
56. Bell B, Rose CL, Damon A. The Veterans Administration longitudinal study of health and aging. Gerontologist 1966;6:179-84.
57. Kapur K, Glass R, Loftus E, Alman J, Feller R. The Veterans Administration longitudinal study of oral health and disease. Aging Hum Dev 1972;3:125-37.
58. Watts T. Fortnightly review: periodontitis for medical practitioners. BMJ 1998;316:993-6.
59. Page RC. Milestones in periodontal research and the remaining critical issues. J Periodont Res 1999;34:331-9.
60. Williams RC, Paquette DW. Periodontal disease diagnosis and treatment: an exciting future. J Dent Educ 1998;62:871-81.
61. Van Winkelhoff AJ, Ramos TE, Slots J. Systemic antibiotic therapy in periodontitis. Periodontol 2000 1996;10:45-78.
62. Crout RJ, Lee HM, Schroeder K, et al. The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol 1996;67:506-14.
63. Gurfinkel EP, Bozovich G. Emerging role of antibiotics in atherosclerosis. Am Heart J 1999;138(suppl pt 2):5375-8.
64. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
65. Wojtowicz-Praga S. Clinical potential of matrix metalloprotease inhibitors. Drugs Res Dev 1999;1:117-29.
66. Graves DT, Delima AJ, Assuma R, Amar S, Oates T, Cochran D. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 1998;69: 1419-25.
67. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-44.
68. Wilson TG. How patient compliance to suggested oral hygiene and maintenance affects periodontal therapy. Dent Clin North Am 1998;42:389-402.
69. Armitage GC. Periodontal diseases: diagnosis. Ann Periodontol 1996;67:1103-13.
70. Williams RC, Paquette DW. Advances in periodontal diagnosis In: Lindhe J, Larring T, eds. Clinical periodontics and implant dentistry. Copenhagen: Munksgaard, 1997:396-419.
71. Hoppichler F, Lechleitner M, Traweger C, et al. Changes of serum antibodies to heat shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996;126:333-8.
72. Butler RT, Kalkwarf KL, Kaldahl WB. Drug-induced gingival hyperplasia; phenytoin, cyclosporine, and nifedipine. J Am Dent Assoc 1987;114:56-60.